6505--Bupropion Tablets 12hr SA Tablets

The Department of Veterans Affairs National Acquisition Center is seeking to procure Bupropion Hydrochloride 12-hour Sustained Action Tablets in three strengths (100mg, 150mg, and 200mg) available in package sizes of 60 and 500 tablets per bottle. This commercial products solicitation (36E79725R0065) requires offerors to submit FDA-approved products manufactured to current Good Manufacturing Practice (cGMP) standards with unique 11-digit National Drug Codes. Key contract requirements include providing pricing for all line items and option years, incorporating a 0.5% Cost Recovery Fee, ensuring packaging in safety-cap bottles, and submitting comprehensive documentation including Letters of Commitment and subcontracting plans. The contract will be awarded to a single vendor for a base year plus four one-year option periods, serving the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. Proposals are due by November 18, 2025, at 2:30 PM Central Time.

This solicitation is designated as a small business set-aside with a size standard of 1,300 employees, and the contract will be distributed through Pharmaceutical Prime Vendor contractors including McKesson Corporation and other specified vendors responsible for order placement and distribution. While specific award values and annual usage quantities are not detailed in the available documentation, the contract covers estimated annual consumption across four federal agencies, indicating substantial volume requirements. The contract spans a five-year period with one base year and four option years, providing medium-term procurement stability. Performance requirements include maintaining FDA compliance and cGMP manufacturing standards throughout the contract period. Distribution will occur through established pharmaceutical prime vendor channels rather than direct government receipt.